2026-06-19
Business summary: The Mosaic Company is the world’s largest integrated producer of phosphate and potash fertilizers, with mining, processing and distribution assets spanning the United States, Canada, and Brazil. It sells crop nutrients and animal-feed ingredients to wholesalers, retailers, cooperatives, and farmers globally. Revenue is almost entirely tied to commodity fertilizer prices, making earnings highly cyclical. The company holds roughly 40% of North American potash capacity and is a top-three global phosphate producer.
- Intrinsic value, DCF: USD 27 per share (range: USD 20 to USD 36)
- Intrinsic value, MEV: USD 25 per share (range: USD 18 to USD 34)
- PE (trailing FY 2025, EPS USD 1.70): 13.5x — cheap in absolute terms but the earnings base is depressed by the cycle trough.
- PEG: Not meaningful at a single-year cyclical trough; normalized PE of roughly 10x on mid-cycle EPS of ~USD 3.00 is more instructive and suggests moderate value.
- Valuation confidence: Low. The fertilizer cycle is the primary driver and is very difficult to forecast; intrinsic value swings enormously depending on the price assumption used for potash and phosphate.
At-a-Glance Scorecard
| Factor | Assessment |
|---|---|
| Business model: simple and sustainable? | Yes — commodity mining/processing; durable but cyclical |
| Moat: present? | Narrow — scale, low-cost mines, vertical integration; partially offset by commodity pricing |
| Management: competent and shareholder aligned? | Mixed — aggressive buybacks at varying prices; CEO Bruce Bodine in place; insider ownership below 1% |
| Intrinsic value, DCF (range) | USD 20 to USD 36 per share |
| Intrinsic value, MEV (range) | USD 18 to USD 34 per share |
| PE / PEG | 13.5x trailing (FY25) / not meaningful |
| Current price vs. intrinsic value | Modestly undervalued; ~15% discount to DCF midpoint at USD 22.90 |
| Margin of safety | ~15% (narrow; insufficient for a high-confidence buy) |
| Free cash flow: strong? | No — FY25 FCF was negative at -USD 534.6M; FY24 barely positive at USD 47.4M |
| Balance sheet: strong? | Weak — net debt of USD 4.8B vs. market cap of ~USD 7.3B; rising capex |
| Biggest single risk | Prolonged commodity price downturn combined with high capex and rising debt |
| Buy price to hit 9% per year over 16 years | ~USD 15 to USD 19 per share (estimate; see Buy Price step) |
| Would I still buy if the market closed for 5 years? | No — too commodity-dependent; outcome highly uncertain |
| Snapshot verdict | Hold / Avoid new entry at current price |
| Valuation confidence | Low |
Inputs used to calculate intrinsic value:
- Normalized mid-cycle owner earnings: ~USD 1.1B per year (average of FY 2021–FY 2025 operating cash flow minus maintenance capex of ~USD 900M, estimated)
- Shares outstanding: 317M (FY 2025, source: stockanalysis.com)
- Discount rate: 10%
- Terminal growth rate: 2%
- MEV: 10x normalized EPS of ~USD 2.50 per share (mid-cycle estimate)
- Net debt used to bridge equity value: USD 4.8B (FY 2025, source: stockanalysis.com)
Deep Dive
Business Understanding
Mosaic mines phosphate rock primarily in Florida and processes it into diammonium phosphate (DAP), monoammonium phosphate (MAP), and MicroEssentials. Potash is mined in Saskatchewan and New Mexico, sold globally through Canpotex, the North American export consortium. The Brazilian subsidiary, Mosaic Fertilizantes, adds distribution and blending assets. Revenue was USD 12.1B in FY 2025, up 8.4% from FY 2024 but sharply below the USD 19.1B peak in FY 2022 (source: stockanalysis.com). The model is straightforward — mine, process, sell — but earnings volatility is extreme because fertilizer prices move in wide commodity cycles. Demand is relatively stable (crops need nutrients every year) but supply additions, currency movements, and Chinese export policy create violent price swings. What would kill this business: a sustained collapse in crop prices reducing farmer purchasing power, cheap Chinese phosphate flooding global markets at scale, or a large new potash entrant.
Competitive Advantage and Positioning
Mosaic’s narrow moat rests on three pillars. First, its Florida phosphate mines are among the largest and lowest-cost in the world. Second, its Esterhazy potash mine in Saskatchewan is world-class and the HydroFloat technology upgrade promises further cost reductions. Third, Canpotex — the joint marketing body with Nutrien — creates a disciplined export channel that moderates price volatility. However, none of these confer true pricing power; Mosaic is a price-taker in global commodity markets, not a price-setter. The moat is being pressured by Chinese LFP battery production consuming phosphoric acid and by Russia/Belarus potash gradually returning to export markets after sanctions disruptions. Competitors include Nutrien (NTR), CF Industries (CF), and ICL Group. The moat is narrow and under pressure, not widening.
Financial Strength: Profitability
The revenue and earnings record over five years illustrates extreme cyclicality. Revenue ranged from USD 11.1B (FY 2024) to USD 19.1B (FY 2022). Net income ranged from USD 175M (FY 2024) to USD 3.6B (FY 2022). Operating margins collapsed from 25% in FY 2022 to 5.6% in FY 2024, recovering partially to 6.8% in FY 2025 (source: stockanalysis.com). EBITDA margins averaged roughly 19% across the five-year cycle, which is not poor for a miner. ROIC peaked above 30% in calendar 2022 and has fallen below 5% in TTM 2025 (source: macrotrends.net). The long-run average ROIC across the prior decade approximates 6–8%, which barely exceeds the cost of capital. This is a critical structural weakness: Mosaic does not consistently earn well above its cost of capital over a full cycle, which limits its ability to compound intrinsic value.
Financial Strength: Balance Sheet
The balance sheet has deteriorated. Net debt rose from USD 2.9B at end-FY 2022 to USD 4.8B at end-FY 2025 (source: stockanalysis.com). Total debt stands at USD 5.1B versus shareholders’ equity of USD 12.1B, giving a debt-to-equity ratio of roughly 0.42x. Long-term debt is USD 4.3B. Cash of USD 277M is thin against the debt load. Goodwill of USD 1.0B is modest relative to total assets of USD 24.5B, so no goodwill bloat risk. However, long-term other liabilities of USD 4.0B include asset-retirement and environmental obligations related to mine reclamation — these are real future cash outflows and should not be dismissed. The balance sheet is manageable but not strong; there is meaningful leverage at a cyclical trough.
Financial Strength: Cash Flow
Free cash flow has deteriorated sharply. FY 2025 FCF was negative USD 534.6M, FY 2024 was barely positive at USD 47.4M, versus USD 1.0B in FY 2023 and USD 2.7B in FY 2022 (source: stockanalysis.com). The culprit is capital expenditure: capex averaged USD 1.3B per year from FY 2021 through FY 2025, driven by the HydroFloat project at Esterhazy and phosphate-facility reliability work. Operating cash flow remains positive (USD 825M in FY 2025) but is being fully consumed and exceeded by capex. Share count has declined from 378M in FY 2021 to 317M in FY 2025, a 16% reduction — a genuine shareholder benefit. However, buybacks of USD 1.7B in FY 2022 were executed near cycle highs, which was capital-allocation error. The dividend of USD 0.88 per share (3.8% yield at USD 22.90) consumes roughly USD 280M annually, which is not covered by FCF in the current environment.
Margin of Safety
At USD 22.90 against a DCF midpoint of USD 27, the discount is approximately 15%. That margin is insufficient given the low confidence in the earnings forecast. A value investor would typically want 30–50% discount when confidence is low and the business is cyclical. If normalized earnings are 20–30% weaker than assumed (a plausible downside), the stock is near fair value today, not cheap. The margin of safety is too thin to provide adequate protection against error.
Mispricing Thesis
The market appears to be pricing MOS as a structurally impaired business rather than a cyclically depressed one. The key insight is that global food demand is structurally rising, phosphate supply is constrained (Chinese export restrictions are tightening the global market), and potash markets look balanced heading into 2026, with Canpotex potentially approaching record shipments. Morningstar pegs fair value at USD 35 (as of early 2026). The market may be extrapolating the FY 2024 trough too far into the future. The gap closes when commodity prices normalize and capex rolls off.
Management and Capital Allocation
Insider ownership is below 1%, which is a yellow flag — management lacks meaningful personal skin in the game. The CEO Bruce Bodine has been in place since 2022. The company has conducted significant buybacks: USD 1.7B in FY 2022, USD 756M in FY 2023, and USD 235M in FY 2024. Regrettably, the heaviest repurchases coincided with prices well above the current level, suggesting capital was not deployed at maximum value. The dividend has been raised steadily but is not covered by FCF at present. Mosaic established a USD 1 billion delayed-draw term loan in June 2026, adding potential further leverage. Capital allocation history is mixed, not exemplary.
Long-Term Outlook
The long-term structural case for phosphate and potash is genuine: a growing global population and expanding middle class require more protein-intensive diets, which demand more fertilizer per calorie produced. China’s domestic focus on LFP batteries competes for phosphate rock, which may constrain export availability of phosphate fertilizer. Mosaic expects 2026 to see record global shipments. However, the company faces real headwinds: sulfur prices have spiked to record levels in early 2026, forcing Mosaic to withdraw its phosphate production guidance; Q1 2026 saw a loss of USD 258M (source: stockanalysis.com). In a recession, crop prices tend to fall, farmer margins compress, and fertilizer demand softens. Mosaic is not recession-resistant.
Risk Assessment
Permanent capital loss could come from: a sustained collapse in DAP/MOP prices over several years combined with USD 1.3B in annual capex and a USD 4.8B debt load; a significant deterioration in the Brazilian operation which carries execution risk; environmental liabilities from mine reclamation exceeding reserves; or a large new potash entrant (Jansen project from BHP is coming online by late decade, adding meaningful supply). Cyclicality is the dominant risk; the company does not have the earnings stability to absorb a prolonged downturn comfortably.
Red Flag Scan
- Declining FCF: Yes — FCF was negative in FY 2025, a serious flag.
- Rising debt without rising earnings: Yes — net debt rose from USD 2.9B to USD 4.8B while earnings fell sharply.
- Misaligned management pay: Moderate concern — high CEO compensation relative to shareholder returns in the past two years; insider ownership minimal.
- Serial acquisitions: No major acquisitions; the Carlsbad divestiture is actually a positive.
- Accounting complexity: Moderate — asset-retirement obligations, pension-related items, and Brazilian currency exposure add complexity.
- Moat erosion: Partial — Chinese phosphate exports and BHP’s Jansen potash project are structural threats.
- Overreliance on one product: Yes — phosphate and potash together represent essentially all revenue; no meaningful diversification.
Disconfirming Evidence
The bear case for Mosaic is compelling and should not be minimized. Phosphate markets face a genuine structural threat from Chinese domestic consolidation: while export restrictions tighten near-term supply, China could reverse policy or technology shifts (like LFP battery adoption plateauing) could free up phosphate for export again. BHP’s Jansen potash mine, expected to begin production by 2026–2027, will add a low-cost, high-quality source of supply to an already-balanced market, likely capping potash price upside for years. Meanwhile, Mosaic’s capex burden is not temporary: maintaining ageing Florida phosphate mines requires sustained reinvestment. FCF has been negative or near zero for two consecutive years, the balance sheet is deteriorating, and Q1 2026 produced a USD 258M loss as sulfuric acid — a key input — hit record prices. The dividend, at USD 0.88 per share, is not covered by FCF and may need to be cut.
Perhaps most damningly, Mosaic’s ROIC over a full cycle barely covers its cost of capital. A business that does not consistently earn above its cost of capital cannot compound intrinsic value; it merely maintains it. On that view, Mosaic deserves to trade at or below book value (USD 35.80 per share, source: stockanalysis.com) — which it does — and may not deserve a meaningful premium to tangible book (USD 32.50 per share) on current facts.
The bull case rests primarily on mean reversion in commodity prices and a structural tightening of global phosphate supply. That is plausible. But commodity mean reversion is notoriously slow and unpredictable, and the company must service USD 5B in debt and USD 1.3B in annual capex throughout any trough. On balance, the bear case is strong enough that the current price does not offer a comfortable margin of safety.
Weighted SWOT
| Factor | Weight | Score (1–10) | Weighted Score |
|---|---|---|---|
| Strengths | |||
| World-class low-cost mines (Esterhazy, Florida phosphate) | 0.30 | 8 | 2.40 |
| Structural demand for fertilizer (global food need) | 0.25 | 7 | 1.75 |
| Canpotex export discipline | 0.20 | 6 | 1.20 |
| Share count reduction (16% over 5 years) | 0.15 | 6 | 0.90 |
| Dividend yield (3.8%) | 0.10 | 5 | 0.50 |
| Strengths subtotal | 1.00 | 6.75 | |
| Weaknesses | |||
| Extreme earnings cyclicality | 0.30 | 3 | 0.90 |
| Negative FCF (FY 2025) and deteriorating balance sheet | 0.30 | 2 | 0.60 |
| Below-cost-of-capital ROIC over full cycle | 0.20 | 3 | 0.60 |
| Low insider ownership (<1%) | 0.10 | 4 | 0.40 |
| Dividend not covered by FCF | 0.10 | 3 | 0.30 |
| Weaknesses subtotal | 1.00 | 2.80 | |
| Opportunities | |||
| Chinese phosphate export restrictions tightening supply | 0.30 | 7 | 2.10 |
| Record 2026 global potash and phosphate demand expected | 0.25 | 6 | 1.50 |
| HydroFloat technology reducing potash unit costs | 0.20 | 6 | 1.20 |
| Brazil recovery on soil nutrient rebuilding | 0.15 | 5 | 0.75 |
| Potential commodity supercycle | 0.10 | 4 | 0.40 |
| Opportunities subtotal | 1.00 | 5.95 | |
| Threats | |||
| BHP Jansen potash adding supply by late decade | 0.30 | 3 | 0.90 |
| Sulfuric acid and input cost spikes (Q1 2026 loss) | 0.25 | 3 | 0.75 |
| Prolonged fertilizer price downturn | 0.25 | 3 | 0.75 |
| China reversal on phosphate export policy | 0.10 | 4 | 0.40 |
| Environmental and reclamation liabilities | 0.10 | 4 | 0.40 |
| Threats subtotal | 1.00 | 3.20 | |
| Net SWOT score (Strengths + Opportunities – Weaknesses – Threats) | +6.70 |
Net score of +6.70 on a 0–20 scale is modestly positive — directionally it suggests the business has genuine merit but is fighting significant headwinds. Treat as directional only.
Scenario Valuations
| Scenario | Revenue Assumption | EBITDA Margin | Normalized Owner Earnings | Discount Rate | Terminal Growth | Intrinsic Value Per Share | Entry Condition | Exit Condition |
|---|---|---|---|---|---|---|---|---|
| Bear | USD 10B (prolonged price weakness, Jansen impact, China reversal) | 12% | ~USD 600M | 11% | 1.5% | USD 10–14 | Avoid; wait for balance-sheet repair | Price falls below book value, FCF turns positive |
| Base | USD 13B (modest recovery by 2027, stable potash, improving phosphate) | 17% | ~USD 1.1B | 10% | 2% | USD 22–30 | USD 18 or below | Price approaches USD 35; thesis intact |
| Bull | USD 17B (supercycle, Chinese supply restriction, record demand) | 24% | ~USD 2.0B | 9% | 2.5% | USD 45–55 | USD 20 or below; commodity upturn confirmed | Price reaches USD 45–50; cycle clearly maturing |
In the base scenario, the current price of USD 22.90 is near the low end of fair value — not a screaming buy. In the bear scenario, there is significant additional downside. Only in the bull scenario does the current price look obviously cheap.
Buy Price and Margin of Safety
| Required Return | Projected Exit Value | Growth Assumption | Max Buy Price | Margin of Safety vs USD 22.90 |
|---|---|---|---|---|
| 9% per year, 16 years (primary hurdle) | USD 27–36 in 2042 (base case exit at DCF midpoint, inflated at 2% per year) | 2% terminal growth; mid-cycle recovery by 2028 | ~USD 15–19 | Negative (current price above this range) |
| 10–11% (conservative) | USD 25–32 in 2042 | Same as above | ~USD 12–16 | Negative |
| 7–8% (optimistic) | USD 30–40 in 2042 | Same with bull-case trajectory | ~USD 18–24 | Near breakeven; marginal |
All figures are range estimates tied to the assumptions above. At USD 22.90, MOS does not meet the 9%-per-year-over-16-years hurdle on base-case assumptions. It would need to be purchased at roughly USD 15–19 to achieve that target, implying a further decline of 17–35% from the current price. Only at an optimistic (7–8%) required return does the current price look marginally viable.
Sell Discipline
Thesis triggers for exit:
- ROIC remains below the cost of capital for three or more consecutive years, signaling a structurally broken return profile.
- Net debt rises above USD 6B, threatening the dividend or covenant compliance.
- The dividend is cut, signaling management has lost confidence in near-term cash generation.
- BHP Jansen production ramp exceeds 4M tonnes per year, structurally resetting potash prices below USD 250 per tonne.
- Phosphate margins compress to below 10% EBITDA on a sustained basis due to Chinese export policy reversal.
Valuation trigger: trim if price reaches USD 38–42 (above the high end of base intrinsic value) while commodity prices are at or above mid-cycle levels.
For existing holders, the stock costs nothing to hold and USD 5 to sell. Given the negative FCF environment, a meaningful rebound in commodity prices is needed before the position generates real returns. Patience is warranted but the thesis requires monitoring closely.
Risk and Opportunity Profile
Risk Score
| Sub-factor | Weight | Score (1=most risky, 10=least risky) | Weighted |
|---|---|---|---|
| Financial Stability | 0.30 | 3 (net debt USD 4.8B; negative FCF) | 0.90 |
| Earnings Volatility | 0.20 | 2 (EPS ranged USD 0.55 to USD 10.17 over 5 years) | 0.40 |
| Business Model Risk | 0.20 | 4 (commodity price-taker; no pricing power) | 0.80 |
| Macro Sensitivity | 0.15 | 3 (highly exposed to crop prices, FX, input costs) | 0.45 |
| Market Risk | 0.15 | 4 (MOS beta ~0.81; sector volatility high) | 0.60 |
| Risk Score | 1.00 | 3.15 / 10 |
A score of 3.15 out of 10 implies high risk — primarily driven by earnings volatility and weak financial stability. The two largest drivers are the USD 4.8B net debt load and the fact that EPS can swing by a factor of 18x across a cycle.
Opportunity Score
| Sub-factor | Weight | Score (1=weakest, 10=strongest) | Weighted |
|---|---|---|---|
| Growth Potential | 0.30 | 5 (modest; tied to commodity cycle recovery) | 1.50 |
| Unit Economics | 0.20 | 4 (ROIC barely covers cost of capital over cycle) | 0.80 |
| Competitive Advantage | 0.20 | 5 (narrow moat; scale and low-cost assets) | 1.00 |
| Valuation Asymmetry | 0.20 | 6 (trading near tangible book; asymmetry exists if cycle turns) | 1.20 |
| Catalysts | 0.10 | 6 (Chinese phosphate restrictions; record 2026 demand expected) | 0.60 |
| Opportunity Score | 1.00 | 5.10 / 10 |
An opportunity score of 5.10 suggests moderate opportunity, driven primarily by valuation asymmetry and near-term catalysts, tempered by weak unit economics.
Classification
Declining, stable, or growing: Cyclical/stable. Revenue and earnings move violently with fertilizer prices but the underlying demand driver (global food production) is structurally growing. The business is not in secular decline.
Peter Lynch classification: Cyclical. MOS is a textbook cyclical stock — a commodity producer whose earnings and stock price move with the commodity cycle. Lynch would caution against buying cyclicals when PE looks low (which it does now at 13.5x), because low PE on a cyclical often means earnings are peaking, not a valuation bargain. Conversely, the very high PE, or losses, at cycle troughs can be the real buying opportunity. On that Lynchian logic, the question is whether FY 2024 and Q1 2026 represent the trough, in which case the stock is interesting.
Charlie Munger classification: Fair business at an arguably fair price. Mosaic is not a great business by Munger’s standards — it does not earn durably high returns on capital and lacks pricing power. It is a fair business: world-class assets, real demand tailwinds, but structurally constrained returns. Munger would likely classify this as “too hard” at the current stage of the cycle given the leverage, the volatile earnings, and the capex demands.
Data Used Versus Ignored
Used:
- Income statement FY 2021–FY 2025 (source: stockanalysis.com, fiscal.ai)
- Balance sheet FY 2021–FY 2025 (source: stockanalysis.com)
- Cash flow statement FY 2021–FY 2025 (source: stockanalysis.com)
- ROIC/ROI historical 2017–2025 (source: macrotrends.net)
- Ownership data: Vanguard ~11.5%, BlackRock ~8.8%, State Street ~5.2%, Cargill major legacy holder (source: pestel-analysis.com, matrixbcg.com — unverified, treat as approximate)
- Company guidance and earnings transcripts: Q4 2025 earnings call (source: Motley Fool), Q1 2026 update, June 2025 revised guidance
- Morningstar fair value estimate of USD 35 (source: morningstar.com)
- Analyst consensus: Hold, mean target USD 26.82 (source: stockanalysis.com)
Ignored:
- Pre-2021 historical data beyond ROIC trend: five years of data is sufficient for a cyclical; pre-2020 data reflects a different management team and pre-COVID conditions less directly comparable.
- Individual analyst price targets beyond the consensus: too much dispersion to be useful individually.
- Short interest data (6.56% of float): noted but not determinative for a long-term analysis.
Unverified figures:
- Institutional ownership percentages (Vanguard, BlackRock, State Street): sourced from secondary aggregators, not directly from 13F filings. Does not materially affect the analysis but treat as approximate.
- Maintenance capex estimate of USD 900M per year: derived by subtracting growth capex judgmentally from total capex; Mosaic does not publish a clean maintenance capex line. This is the single biggest source of uncertainty in the owner-earnings calculation and therefore in the DCF.
Summary and Verdict
Mosaic is a world-class fertilizer producer at a cyclical trough. Its phosphate and potash assets are genuinely valuable, demand for its products is structurally supported by global food needs, and Chinese export restrictions provide a near-term tailwind for phosphate prices. The stock trades at roughly 0.64x tangible book value — a sign of deep cyclical pessimism.
The problem is that the margin of safety at USD 22.90 is insufficient for a low-confidence, high-cyclicality investment. The hurdle rate of 9% per year over 16 years implies a buy price of roughly USD 15–19 on base-case assumptions — a level the stock has not reached, but which is not implausible given the negative FCF, the rising debt, and the Q1 2026 loss. Morningstar’s USD 35 fair value is credible but relies on a commodity recovery that is not yet confirmed.
Intrinsic value range: DCF USD 20–36, MEV USD 18–34. Midpoint of DCF: USD 27.
At USD 22.90, MOS does not meet the 9%-per-year-over-16-years hurdle on base-case assumptions. It would meet the hurdle somewhere in the USD 15–19 range. At an optimistic 7–8% required return, the current price is marginally viable.
Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Always perform your own due diligence or consult with a financial advisor before making investment decisions.
